1. Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods 2019;8(3):92. [
DOI:10.3390/foods8030092] [
PMID] [
]
2. Weerkamp A. Thermophilic bacteria. Biosystems 1974;6(1):69-70. [
DOI:10.1016/0303-2647(74)90023-9]
3. Fares C, Menga V, Martina A, Pellegrini N, Scazzina F, Torriani S. Nutritional profile and cooking quality of a new functional pasta naturally enriched in phenolic acids, added with β-glucan and Bacillus coagulans GBI-30, 6086. J Cereal Sci 2015;65:260-6. [
DOI:10.1016/j.jcs.2015.07.017]
4. Kobus-Cisowska J, Szymanowska D, Maciejewska P, Szczepaniak O, Kmiecik D, Gramza-Michałowska A, et al. Enriching novel dark chocolate with Bacillus coagulans as a way to provide beneficial nutrients. Food Func 2019;10(2):997-1006. [
DOI:10.1039/C8FO02099J] [
PMID]
5. Salvetti E, Orrù L, Capozzi V, Martina A, Lamontanara A, Keller D, et al. Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study. Appl Microbiol Biotechnol 2016;100(10):4595-605. [
DOI:10.1007/s00253-016-7416-9] [
PMID]
6. Scott KP, Jean-Michel A, Midtvedt T, van Hemert S. Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis 2015;26(1):25877. [
DOI:10.3402/mehd.v26.25877] [
PMID] [
]
7. Cao J, Yu Z, Liu W, Zhao J, Zhang H, Zhai Q, et al. Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases. J Funct Foods 2020; 64:103643. [
DOI:10.1016/j.jff.2019.103643]
8. Gong D, Wilson PW, Bain MM, McDade K, Kalina J, Hervé-Grépinet V, et al. Gallin; an antimicrobial peptide member of a new avian defensin family, the ovodefensins, has been subject to recent gene duplication. BMC Immunol 2010;11(1):1-15. [
DOI:10.1186/1471-2172-11-12] [
PMID] [
]
9. Dolin B. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Findings Experim Clin Pharmacol 2009;31(10):655-9. [
DOI:10.1358/mf.2009.31.10.1441078] [
PMID]
10. Endres J, Clewell A, Jade K, Farber T, Hauswirth J, Schauss A. Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 2009;47(6):1231-8. [
DOI:10.1016/j.fct.2009.02.018] [
PMID] [
]
11. Jensen GS, Benson KF, Carter SG, Endres JR. GanedenBC30™ cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro. BMC Immunol 2010;11(1):1-14. [
DOI:10.1186/1471-2172-11-15] [
PMID] [
]